Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
NVL-520 by Nuvalent for Non-Small Cell Lung Cancer: Likelihood of Approval
NVL-520 is under clinical development by Nuvalent and currently in Phase II for Non-Small Cell Lung Cancer. According to GlobalData,...
Data Insights
NVL-520 by Nuvalent for Solid Tumor: Likelihood of Approval
NVL-520 is under clinical development by Nuvalent and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...